MIRA INFORM REPORT

 

 

Report Date :

21.03.2011

 

IDENTIFICATION DETAILS

 

Name :

AADIVIGHNESH CHEM PRIVATE LIMITED

 

 

Registered Office :

7A, Badrinath Apartment, Shimpoli Road, Near Soni Wadi, Borivali (West), Mumbai – 400 092, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2009

 

 

Date of Incorporation :

08.07.2004

 

 

Com. Reg. No.:

11-147379

 

 

CIN No.:

[Company Identification No.]

U51397MH2004PTC147379

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMA23935C

 

 

PAN No.:

[Permanent Account No.]

AAECA8478P

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Trader of Pharma Chemicals. 

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (45)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 18000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track. Trade relations are reported as fair. Business is active. Payments terms are reported to be usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – April 1, 2010

 

Country Name

Previous Rating

(31.12.2009)

Current Rating

(01.04.2010)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INFORMATION DECLINED BY

 

Name :

Mr. Shantilal

Designation :

Accounts Department

Date :

18.03.2011

 

 

LOCATIONS

 

Registered Office :

7A, Badrinath Apartment, Shimpoli Road, Near Soni Wadi, Borivali (West), Mumbai – 400 092, Maharashtra, India

Tel. No.:

91-22-28923618

Fax No.:

91-22-28920082

E-Mail :

aadi@vsnl.net

 

 

DIRECTORS

 

As on 30.09.2009

 

Name :

Mr. Bipin Chinubhai Shah

Designation :

Director

Address :

802, Radheshyam Apartment, Datta Pada Road, Off. S V Road, Borivali (W),  Mumbai – 400092, Maharashtra, India

Date of Birth/Age :

30.08.1945

Date of Appointment :

08.07.2004

 

 

Name :

Ms. Indira Bipin Shah

Designation :

Director

Address :

802, Radheshyam Apartment, Datta Pada Road, Off. S V Road, Borivali (W),  Mumbai – 400092, Maharashtra, India

Date of Birth/Age :

20.08.1947

Date of Appointment :

08.07.2004

 

 

Name :

Mr. Amish Bipin Shah

Designation :

Director

Address :

802, Radheshyam Apartment, Datta Pada Road, Off. S V Road, Borivali (W),  Mumbai – 400092, Maharashtra, India

Date of Birth/Age :

25.04.1971

Date of Appointment :

08.07.2004

 

 

Name :

Mr. Devang Bipin Shah

Designation :

Director

Address :

802, Radheshyam Apartment, Datta Pada Road, Off. S V Road, Borivali (W),  Mumbai – 400092, Maharashtra, India

Date of Birth/Age :

21.11.1977

Date of Appointment :

22.07.2004

 

 

KEY EXECUTIVES

 

Name :

Mr. Shantilal

Designation :

Accounts Department

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2009

 

Names of Shareholders

 

 

No. of Shares

Bipin Chinubhai Shah

 

2500

Indira Bipin Shah

 

2500

Amish Bipin Shah

 

2500

Devang Bipin Shah

 

2500

Total

 

10000

 

As on 30.09.2009

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Directors or relatives of directors

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Trader of Pharma Chemicals. 

 

 

 

 

GENERAL INFORMATION

 

Suppliers :

  • Aarti Drugs Limited
  • Ajanta Enterprises
  • Amri India Private Limited
  • Anphar Laboratories
  • Anuh Pharma Limited
  • Avik Pharmaceuticals Limited
  • Auctus Pharma Limited
  • Bal Pharma Limited
  • Cadila Pharmaceuticals Limited
  • Harika Drugs Private Limited
  • Hetero Drugs Limited
  • Hetero Labs Limited
  • IPCA Laboratories Limited
  • Lee Pharma Limited
  • Rantus Pharma Private Limited
  • Symed Labs Limited
  • Sainor Pharma
  • SMS Pharmaceuticals Limited
  • Sanior Pharma Private Limited
  • Vaikunth Chemicals Private Limited
  • Vani Pharma Labs Limited
  • Wockhardt Limited
  • Zyden Gentec Limited

 

 

Customers :

  • Cevallos Laboratories
  • Cevallos Salud
  • Ditines International
  • Genix Industrial Farmaceutical
  • Henrifarma Produtos Quimicos
  • Pt. Laksanawan Laras
  • Pemar 2004 SL
  • Select Chemie
  • SSB Pharma
  • Sica S.A. DE C.V.
  • Sagran SRL
  • Unico and Company
  • Valdequimica Produtos Quimcos
  • Yes Pharma

 

 

No. of Employees :

Information declined by the management

 

 

Bankers :

  • HDFC Bank
  • Canara Bank

 

 

Facilities :

Secured Loans

31.03.2009

Rs. In Millions

31.03.2008

Rs. In Millions

HDFC Car Loan A/c

0.289

0.492

Canara Bank Car loan A/c

0.716

0.000

Total

1.005

0.492

 

Unsecured Loans

31.03.2009

Rs. In Millions

31.03.2008

Rs. In Millions

Bipin C. Shah

0.318

0.318

Total

0.318

0.318

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

J.S. Joshi and Company

Chartered Accountants

Address :

10/ 11, Star Trade Centre, Sodawala Lane, Borivli (West), Mumbai – 400 092, Maharashtra, India

Tel. No.:

91-22-28920045/ 28914499

 

 

CAPITAL STRUCTURE

 

As on 31.03.2009

 

Authorised Capital :

No. of Shares

Type

Value

Amount

50000

Equity Shares

Rs.10/- each

Rs.0.500 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

10000

Equity Shares

Rs.10/- each

Rs.0.100 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2009

31.03.2008

31.03.2007

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

0.100

0.100

0.100

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

4.392

1.877

1.396

4] (Accumulated Losses)

0.00

0.000

0.000

NETWORTH

4.492

1.977

1.496

LOAN FUNDS

 

 

 

1] Secured Loans

1.005

0.492

0.000

2] Unsecured Loans

0.318

0.318

0.318

TOTAL BORROWING

1.323

0.810

0.318

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

5.815

2.787

1.813

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

1.815

0.948

0.181

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

4.228

0.146

0.600

 

Sundry Debtors

13.239

15.837

9.592

 

Cash & Bank Balances

3.356

2.220

1.529

 

Other Current Assets

0.000

0.000

0.000

 

Loans, Advances & Deposits

7.790

1.046

4.022

Total Current Assets

28.613

19.249

15.743

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

22.481

16.422

13.243

 

Other Current Liabilities

0.000

0.000

0.000

 

Provisions

2.145

1.003

0.885

Total Current Liabilities

24.626

17.425

14.128

Net Current Assets

3.987

1.824

1.615

 

 

 

 

MISCELLANEOUS EXPENSES

0.013

0.015

0.017

 

 

 

 

TOTAL

5.815

2.787

1.813

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2009

31.03.2008

31.03.2007

 

SALES

 

 

 

 

 

Income

92.791

64.643

63.954

 

 

Other Income

1.367

1.135

1.375

 

 

TOTAL                                    

94.158

65.778

65.329

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Sales

89.865

64.795

56.667

 

 

Administrative, Selling & Other Expenses

 

 

7.527

 

 

Miscellaneous Expenses Written off

 

 

0.002

 

 

TOTAL                                    

89.865

64.795

64.196

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION

4.293

0.983

1.133

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

0.330

0.159

0.036

 

 

 

 

 

 

PROFIT BEFORE TAX

3.963

0.824

1.097

 

 

 

 

 

Less

TAX                                                                 

1.443

0.316

0.477

 

 

 

 

 

 

PROFIT AFTER TAX

2.520

0.508

0.620

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

1.877

1.396

0.776

 

 

 

 

 

 

Less: Income Tax Adjustment

0.005

0.027

--

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

4.392

1.877

1.396

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

92.791

64.643

NA

 

 

Export Goods

72.749

72.749

NA

 

 

Other Earnings

6.145

1.282

NA

 

TOTAL EARNINGS

171.685

138.674

NA

 

 

 

 

 

 

Earnings Per Share (Rs.)

252.00

48.10

NA

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2009

31.03.2008

31.03.2007

PAT / Total Income

(%)

2.67

0.78

0.94

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

4.27

1.27

1.71

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

13.02

4.07

6.88

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.88

0.41

0.73

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

5.77

9.22

9.65

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.16

1.10

1.11

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Details of Sundry Creditors: (Partial)

 

Particulars

 

31.03.2009

(Rs. in millions)

31.03.2008

(Rs. in millions)

31.03.2007

(Rs. in millions)

Sundry Creditors For Goods

 

 

 

Aarti Drugs Limited

0.360

0.000

0.000

Ajanta Enterprises

1.992

0.000

0.000

Apex Health Care Limited

0.032

0.338

0.000

Amri India Private Limited

0.041

0.000

0.000

Anphar Laboratories

0.914

0.145

0.008

Anuh Pharma Limited

0.868

0.000

0.000

Avik Pharmaceuticals Limited

1.550

1.482

0.000

Auctus Pharma Limited

0.010

0.000

0.000

Bal Pharma Limited

0.057

0.000

0.000

Cadila Pharmaceuticals Limited

0.770

0.146

0.000

 

 

 

 

Sundry Creditors For Other

 

 

 

Feromet S.A.

0.100

0.000

0.000

OH Nam Trading

0.160

0.000

0.000

P.T. Laksanwan Lars

0.070

0.000

0.000

Sandoz Private Limited

(0.002)

0.000

0.000

Sica S.A.De Cv

0.046

0.084

0.047

Susanne Wegener

0.051

0.000

0.000

 

 

 

 

Sundry Creditors For Expenses

 

 

 

J. S. Joshi and Company

0.020

0.020

0.047

Maya Forwarding Agencies

0.004

0.057

0.000

Ramarao Cargolines Private Limited

0.030

0.031

0.000

Target Logistics Ind Private Limited

0.028

0.000

0.000

The Travel Solutions Company

0.016

0.000

0.000

Worldlink Airfreight Logistics

0.244

0.489

0.541

Yes Pharma Limited

8.408

0.000

0.000

 

FIXED ASSETS:

 

·         Air Conditioner

·         Computer

·         Furniture and Fixture

·         Fax

·         Motor Car

·         Type Writer

·         Motor Car Honda

·         Office Equipment

·         Motor Car Innova

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.45.09

UK Pound

1

Rs.72.59

Euro

1

Rs.62.95

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

45

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.